Moleculin Biotech (MBRX) Return on Equity [ROE] (2016 - 2026)
Moleculin Biotech (MBRX) posted Return on Equity [ROE] of -200.96% for Q2 2026, up 168.09 percentage points from -369.05% a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2025, Moleculin Biotech's Return on Equity [ROE] came in at -191.52%, down 65.07 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three consecutive years, with a five-year change of -87.39 percentage points (FY2020 to FY2025).
- In prior years, Moleculin Biotech's Return on Equity [ROE] was -126.45% in FY2024 (-55.15 pp), -71.30% in FY2023 (-24.58 pp), -46.71% in FY2022 (+0.76 pp) and -47.48% in FY2021 (+56.66 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q4 2024.
- On a year-over-year basis, Return on Equity [ROE] increased in 1 of the last five quarters, with an average year-over-year change of -72.64 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2026, with a gain of 168.09 percentage points; the weakest was Q2 2025, with a drop of 244.13 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Moleculin Biotech | 2.78 Mn | 2.78 Mn | - | -200.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -200.96% |
| Jun 30, 2025 | -369.05% |
| Mar 31, 2025 | -207.26% |
| Dec 31, 2024 | -186.17% |
| Sep 30, 2024 | -157.07% |
| Jun 30, 2024 | -124.91% |
| Mar 31, 2024 | -99.99% |
| Dec 31, 2023 | -89.70% |
| Sep 30, 2023 | -73.63% |
| Jun 30, 2023 | -71.89% |
| Mar 31, 2023 | -65.23% |
| Dec 31, 2022 | -55.40% |
| Sep 30, 2022 | -46.16% |
| Jun 30, 2022 | -37.22% |
| Mar 31, 2022 | -31.59% |
| Dec 31, 2021 | -28.66% |
| Sep 30, 2021 | -24.59% |
| Jun 30, 2021 | -20.37% |
| Mar 31, 2021 | -32.29% |
| Dec 31, 2020 | -100.10% |
API Access
Moleculin Biotech Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();